{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T12:31:17Z","timestamp":1777120277523,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.mehy.2020.109749","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:42:31Z","timestamp":1587555751000},"page":"109749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["May IL-17 have a role in COVID-19 infection?"],"prefix":"10.1016","volume":"140","author":[{"given":"Matteo","family":"Megna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109749_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100289","article-title":"The coronavirus 2019-nCoV epidemic: is hindsight 20\/20?","volume":"20","author":"Malta","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.mehy.2020.109749_b0010","unstructured":"Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation and treatment coronavirus (COVID-19). 2020 Mar 8. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554776\/ PubMed PMID: 32150360."},{"issue":"10223","key":"10.1016\/j.mehy.2020.109749_b0015","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109749_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25801","article-title":"Tocilizumab treatment in COVID-19: a single center experience","author":"Luo","year":"2020","journal-title":"J Med Virol"},{"issue":"10223","key":"10.1016\/j.mehy.2020.109749_b0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109749_b0030","first-page":"1","article-title":"Should patients stop their biologic treatment during the COVID-19 pandemic","author":"Bashyam","year":"2020","journal-title":"J Dermatolog Treat"},{"issue":"15","key":"10.1016\/j.mehy.2020.109749_b0035","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1128\/JVI.00724-14","article-title":"Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function","volume":"88","author":"Hou","year":"2014","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.mehy.2020.109749_b0040","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.4049\/jimmunol.0900995","article-title":"Critical role of IL-17RA in immunopathology of influenza infection","volume":"183","author":"Crowe","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2020.109749_b0045","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/jmv.25406","article-title":"Th17 serum cytokines in relation to laboratory-confirmed respiratory viral infection: a pilot study","volume":"91","author":"Antalis","year":"2019","journal-title":"J Med Virol"},{"issue":"9","key":"10.1016\/j.mehy.2020.109749_b0050","first-page":"190109","article-title":"The protective and pathogenic role of IL-17 in viral infection: friend or foe?","volume":"210","author":"Wen-Tao","year":"2019","journal-title":"Open Biol"},{"issue":"10224","key":"10.1016\/j.mehy.2020.109749_b9000","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S0140-6736(20)30305-6","article-title":"Reducing mortality from 2019-nCoV: host-directed therapies should be an option","volume":"395","author":"Zumla","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109749_b9005","unstructured":"A randomized, blinded, controlled, multicenter clinical trial to evaluate the efficacy and safety of Ixekizumab combined with conventional antiviral drugs in patients with novel coronavirus pneumonia (COVID-19). Available from http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=50251."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720304229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720304229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:22:56Z","timestamp":1759692176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720304229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":12,"alternative-id":["S0306987720304229"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109749","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"May IL-17 have a role in COVID-19 infection?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109749"}}